US and Brazilian presidents meet in Washington on March 19, 2019.

    US-Brazil Relations: From Complex Times to the Trump-Bolsonaro Era

    US-Brazil relations during the early 21st century reflect the ongoing aspirations of two nations ...

    Efavirenz

    US Health Journal Praises Brazil for Playing Hard Against AIDS Drugs Makers

    Brazil has set an example to other developing countries by employing "creative measures" to ...

    Angels of Brazil

    UN Wants Brazil to End Discrimination on AIDS Treatment

    With the goal of promoting awareness of the link between AIDS and tuberculosis and ...

    Abbott's Kaletra AIDS drug

    US AIDS Foundation Applauds Brazil for Defeating Abbott on AIDS Drug

    US-based AIDS Healthcare Foundation (AHF), the American largest HIV/AIDS healthcare, prevention and education provider, ...

    Merck's anti-AIDS drug Stocrin (Efivarenz)

    Brazil Threatens to Break More Drugs Patents If Prices Don’t Go Down

    Right after signing the decree breaking the patent of Merck's anti-AIDS drug Efavirenz, Brazilian ...

    US Foundation Tells Brazil to Break Patents If Needed to Keep AIDS Program Going

    On the heels of an article published yesterday, January 3, in the Boston Globe, ...

    Second-Line Drugs Put Big Burden on Brazil’s AIDS Program

    The deputy director of Brazil’s Ministry of Health’s National Sexually Transmitted Diseases and AIDS ...

    AIDS Drugs Prices Threaten Brazil’s Whole Health System

    Last week, the UN AIDS program once again praised Brazil’s AIDS program. However, also ...

    Brazil’s Universal Care for AIDS Patients at a Dead End

    Rising costs for drugs is threatening Brazil’s ability to provide free AIDS medication to ...